ResearchPeptide
NAD+
Published Research
PubMed-indexed studies for NAD+
Impaired nicotinamide adenine dinucleotide (NAD(+) ) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment.
View on PubMed →The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.
View on PubMed →Evaluation of NAD(+) precursors for improved metabolism and productivity of antibody-producing CHO cell.
View on PubMed →Nicotinamide Adenine Dinucleotide-Loaded Lubricated Hydrogel Microspheres with a Three-Pronged Approach Alleviate Age-Related Osteoarthritis.
View on PubMed →A Targeting Senescence and Recycling Intracellular Nicotinamide Adenine Dinucleotide Strategy for Attenuation of Senescence-Associated Phenotypes.
View on PubMed →A zebrafish model of nicotinamide adenine dinucleotide (NAD(+)) deficiency-derived congenital disorders.
View on PubMed →Research-Grade NAD+
⚠️ For laboratory research only. Not for human use.